Patent intelligence · US
US 6367479
METHOD OF FORCING THE REVERSE TRANSPORT OF CHOLESTEROL FROM A BODY PART TO THE LIVER WHILE AVOIDING HARMFUL DISRUPTIONS OF HEPATIC CHOLESTEROL HOMEOSTASIS, AND PHARMACEUTICAL COMPOSITIONS AND KIT RELATED THERETO
METHOD OF FORCING THE REVERSE TRANSPORT OF CHOLESTEROL FROM A BODY PART TO THE LIVER WHILE AVOIDING HARMFUL DISRUPTIONS OF HEPATIC CHOLESTER…
Patent details — US 6367479
- Jurisdiction
- US
- Status
- expired
- Grant date
- Apr 9, 2002
- Expiration
- Apr 4, 2022
- Applicant
- Esperion LUV Development, Inc.
- Claims
- 15
- CPC classes
- A61K, A61K31/685, A61K38/02, A61K9/127
Quick answer
US 6367479 (METHOD OF FORCING THE REVERSE TRANSPORT OF CHOLESTEROL FROM A BODY PART TO THE LIVER WHILE AVOIDING HARMFUL DISRUPTIONS OF HEPATIC CHOLESTEROL HOMEOSTASIS, AND PHARMACEUTICAL COMPOSITIONS AND KIT RELATED THERETO) is held by Esperion LUV Development, Inc.. Status: expired. Granted Apr 9, 2002. Expires Apr 4, 2022 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Esperion LUV Development, Inc.
- Grant date
- Expiration
- Claims
- 15
- CPC classes
- A61K, A61K31/685, A61K38/02, A61K9/127
More from Esperion LUV Development, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12404227
Methods of making bempedoic acid and compositions of the same
granted -
US 12398087
Methods of making bempedoic acid and compositions of the same
granted -
US 12344578
Salt forms of bempedoic acid and methods for using the same
granted -
US 11987548
Methods of making bempedoic acid and compositions of the same
granted -
US 11926584
Methods of making bempedoic acid and compositions of the same
granted -
US 11760714
Methods of making bempedoic acid and compositions of the same
granted -
US 11744816
Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
granted -
US 11613511
Methods of making bempedoic acid and compositions of the same
granted
Frequently asked questions
What is US patent 6367479?
US 6367479 (METHOD OF FORCING THE REVERSE TRANSPORT OF CHOLESTEROL FROM A BODY PART TO THE LIVER WHILE AVOIDING HARMFUL DISRUPTIONS OF HEPATIC CHOLESTEROL HOMEOSTASIS, AND PHARMACEUTICAL COMPOSITIONS AND KIT RELATED THERETO) is held by Esperion LUV Development, Inc.. Status: expired. Granted Apr 9, 2002. Expires Apr 4, 2022 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6367479?
Esperion LUV Development, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 55 pharmaceutical patents for this assignee.
When does US 6367479 expire?
Our index shows an expiration date of Apr 4, 2022 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.